Accutane (isotretinoin) and psychiatric adverse effects

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 1, 2003, Pages 66-

  Wooltorton, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ISOTRETINOIN; ORAL CONTRACEPTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

ACNE VULGARIS; BRAIN PSEUDOTUMOR; CHEILITIS; CORNEA OPACITY; DEPRESSION; DRY EYE; DRY SKIN; FATIGUE; HAIR LOSS; HEADACHE; HUMAN; HYPEROSTOSIS; HYPERTRIGLYCERIDEMIA; LIVER TOXICITY; MENTAL HEALTH; MYALGIA; NAUSEA; NIGHT BLINDNESS; SHORT SURVEY; SUICIDAL BEHAVIOR; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VOMITING;

EID: 0037286319     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Webster GF. Acne vulgaris. BMJ 2002;325:465-9.
2. Madden WS, Landells ID, Poulin Y, Searles GE, Smith KC, Tan JK, et al. Treatment of acne vulgaris and prevention of acne scarring: Canadian consensus guidelines. J Cutan Med Surg 2000;4 (Suppl 1):S2-13.
3. Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol 2002;46:505-9.
4. Polifka JE, Friedman JM. Medical genetics: 1. Clinical teratology in the age of genomics. CMAJ 2002;167(3):265-73.
5. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:515-9.
6. Important safety information on Accutane [Dear Healthcare Professional Letter]. Mississauga (ON): Hoffman-La Roche Limited; March 2001. Available (PDF format): www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/advisory/industry/ accutane_e.pdf (accessed 2002 Nov 29).
7. Safety Alert: Accutane (isotretinoin) [Dear Doctor Letter]. Nutley (NJ): Roche Laboratories Inc.; Sept 2002 Available: www.fda.gov/medwatch/SAFETY/2002/safety02.htm#accuta (accessed 2002 Dec 4).
8. Accutane [product monograph]. In:Compendium of pharmaceuticals and specialties. Ottawa: Canadian Pharmacists Association; 2002. p. 11-3.
9. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45(5):S150-7.
10. Fung MA, Frohlich JJ. Common problems in the management of hypertriglyceridemia. CMAJ 2002;167(11):1261-6.
11. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia arreata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-50.
12. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17(1):25-32.
13. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000;136:1231-6.